Eli Lilly CEO David Ricks joins CNBC’s Meg Tirrell and the ‘Squawk Box’ team to break down the company’s latest earnings report and its clinical trial results for weight-loss drug tirzepatide.
You May Also Like
About the Author: Chaz Cutler
My name is Chasity. I love to follow the stock market and financial news!